India  

Canada: No Need To Speculate: Ontario Court Of Appeal Affirms Denial Of Certification In Pharmaceutical Product Liability Class Action Based On Increased Risk Of Harm - Cassels

Mondaq Wednesday, 24 April 2024 ()
Can consumers subject to an increased risk of harm from a product successfully certify a product liability class action even though the harm has not yet, and may never...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Norfolk Southern Offers Settlement to Resolve Lawsuits Related to 2023 Derailment [Video]

Norfolk Southern Offers Settlement to Resolve Lawsuits Related to 2023 Derailment

Norfolk Southern Offers , Settlement to Resolve Lawsuits , Related to 2023 Derailment. Train operator Norfolk Southern has agreed to pay $600 million as part of a settlement to a class-action lawsuit..

Credit: Wibbitz Top Stories     Duration: 01:31Published
Nvidia & darpa biohybrid [Video]

Nvidia & darpa biohybrid

https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..

Credit: Rumble     Duration: 55:45Published

Related news from verified sources

Canada: Court Of Appeal Upholds Certification Denial And Dismissal Of Drug Recall Class Action - Osler, Hoskin & Harcourt LLP

The Court of Appeal for Ontario released its decision yesterday in Palmer v. Teva Canada Limited, affirming the denial of certification and dismissal of a...
Mondaq